|
(Health-NewsWire.Net, December 11, 2015 ) GlobalData's Partnerships, Licensing, Investments and M&A Deals and Trends for September 2015 in Pharmaceuticals report is an essential source of data and trend analysis on partnerships, licensing, mergers and acquisitions (M&As) and financings in the pharmaceuticals industry. The report provides detailed information on partnership and licensing transactions, M&As, equity/debt offerings, private equity, and venture financing registered in the pharmaceuticals industry in September 2015. The report portrays detailed comparative data on the number of deals and their value in the last six months, subdivided by deal types, various therapy areas, and geographies. Additionally, the report provides information on the top financial advisory firms in the pharmaceuticals industry.
Data presented in this report is derived from GlobalDatas proprietary in-house Pharmaceuticals eTrack deals database and primary and secondary research.
To Get Sample Copy of Report visit @ http://www.researchmoz.us/enquiry.php?type=S&repid=487735
Scope
- Analysis of the market trends for the pharmaceutical industry in the global arena.
- Review of deal trends in the cardiovascular, central nervous system, dermatology, ear nose throat disorders, gastrointestinal, genito urinary system and sex hormones, hematological disorders, hormonal disorders, immunology, infectious disease, male health, metabolic disorders, mouth and dental disorders, musculoskeletal, oncology, ophthalmology, respiratory, toxicology, and women's health segments.
- Analysis of partnerships, licensing, M&As, equity/debt offerings, private equity, and venture financing deals in the pharmaceutical industry.
- Analysis of therapy areas which are very active in terms of venture capital financing, partnerships, licensing agreements, equity/debt offerings, and M&As.
- Analysis of deals based on different payment modes, including upfront and milestone payments, primarily in partnerships and licensing agreements in the pharmaceutical industry.
- Analysis of partnership and licensing deals based on clinical stage of development of products.
- Summary of the pharmaceutical deals globally in the six months.
- Information on the top deals happened in the pharmaceutical industry.
- Geographies covered include - North America, Europe, Asia Pacific, South & Central America, and the Middle East & Africa.
- League tables of financial advisors in M&As and equity/debt offerings. This includes key advisors such as Morgan Stanley, Credit Suisse, and Goldman Sachs.
Reasons to buy
- Enhance your decision making capability in a more rapid and time sensitive manner.
- Find out the major deal performing segments for investments in your industry.
- Evaluate the types of companies which are entering into partnership or licensing agreements; divesting and acquiring assets.
- Identify companies that are aggressively looking to raise capital in the market
- Evaluate niche therapy areas that are receiving majority of the upfront and milestone payments in the pharmaceutical industry.
- Identify the key venture capitalists, who are financing the pharmaceutical and biotech companies.
- Evaluate the clinical development stages where majority of the partnerships and licensing agreements are happening.
- Do deals with an understanding of how competitors are financed, and the mergers and partnerships that have shaped the pharmaceutical industry.
- Identify growth segments and opportunities in each region within the industry.
- Look for key financial advisors where you are planning to raise capital from the market or for acquisitions within the industry.
Browse Detail Report With TOC @ http://www.researchmoz.us/partnerships-licensing-investments-and-manda-deals-and-trends-for-september-2015-in-pharmaceuticals-report.html
Table of Contents
1 Table of Contents 2
1.1 List of Tables 6
1.2 List of Figures 9
2 Pharmaceuticals & Healthcare, Global, Deal Summary 12
2.1 Pharmaceuticals & Healthcare, Global, Deal Analysis, September 2015 12
2.2 Pharmaceuticals & Healthcare, Global, Major Deals, September 2015 14
2.2.1 Gilead Sciences Raises USD10 Billion in Public Offering Notes 14
2.2.2 Biogen Raises USD6 Billion in Public Offering Notes 14
2.2.3 Concordia Healthcare Acquires Amdipharm Mercury for USD3.54 Billion 15
2.2.4 Sanofi Prices Public Offering of Notes for USD2.3 Billion 16
2.2.5 Amgen Enters into Licensing Agreement with Xencor 16
2.3 Pharmaceuticals & Healthcare, Global, by Type, Number of Deals, September 2015 18
2.4 Pharmaceuticals & Healthcare, Global, by Type, Deal Values, September 2015 19
3 Pharmaceuticals and Healthcare, Global, Deals, Summary, by Type 20
3.1 Pharmaceuticals & Healthcare, Global, M&A, September 2015 20
3.1.1 Top M&A Deals in September 2015 21
3.1.2 Pharmaceuticals & Healthcare, Global, M&A Deals by Therapy Area, April 2015 - September 2015 22
3.2 Pharmaceuticals & Healthcare, Global, Equity Offering Deals, September 2015 24
3.2.1 Top Equity Offering Deals in September 2015 25
3.2.2 Pharmaceuticals & Healthcare, Global, Equity Offering Deals by Therapy Area, April 2015 - September 2015 26
3.3 Pharmaceuticals & Healthcare, Global, Private Equity and Venture Capital Deals, September 2015 28
3.3.1 Top PE/VC Deals in September 2015 29
3.3.2 Pharmaceuticals & Healthcare, Global, PE/VC by Therapy Area, September 2015 30
3.3.3 Pharmaceuticals & Healthcare, Global, Venture Capital Deals by Stage of Financing, September 2015 31
3.3.4 Pharmaceuticals & Healthcare, Global, Top Venture Financing Firms, April 2015-September 2015 33
3.3.5 Pharmaceuticals & Healthcare, Global, Top VC Backed Companies, April 2015-September 2015 34
4 Pharmaceuticals & Healthcare, Global, Partnership Deals, September 2015 35
4.1 Pharmaceuticals & Healthcare, Global, Partnership Deals, September 2015 35
4.2 Pharmaceuticals & Healthcare, Global, Partnership Deals by Therapy Area, April 2015 - September 2015 37
4.3 Pharmaceuticals & Healthcare, Global, Partnership Deals by Upfront and Milestone Payments and Deal Values (US$ m), September 2015 38
4.3.1 Pharmaceuticals & Healthcare, Global, Top Partnership Deals by Payment Mode, September 2015 39
4.4 Pharmaceuticals & Healthcare, Global, Partnership Deals by Therapy Area, by Upfront and Milestone Payments and Deal Values (US$ m), April 2015 - September 2015 40
4.5 Pharmaceuticals & Healthcare, Global, Partnership Deals by Phase, Number Of Deals, April 2015 - September 2015 42
4.6 Pharmaceuticals & Healthcare, Global, Partnership Deals by Phase, Deal Values (US$ m), April 2015 - September 2015 43
4.7 Pharmaceuticals & Healthcare, Global, Partnership Deals by Phase, by Upfront & Milestone Payments and Deal Values (US$ m), April 2015 - September 2015 45
5 Pharmaceuticals & Healthcare, Global, Licensing Agreements, September 2015 47
5.1 Pharmaceuticals & Healthcare, Global, Licensing Agreements, September 2015 47
5.2 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals, Upfront and Milestone Payments and Deal Values (US$ m), September 2015 49
5.3 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals by Therapy Area, Total Deal Values (US$ m), April 2015 - September 2015 51
5.4 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals by Therapy Area, Upfront Payments and Milestone Payments (US$ m), April 2015 - September 2015 53
5.5 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals by Phase, Total Deal Values (US$ m), April 2015 - September 2015 55
5.6 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals by Phase, Upfront Payments and Milestone Payments (US$ m), April 2015 - September 2015 57
5.6.1 Pharmaceuticals & Healthcare, Global, Top Licensing Agreements by Deal Value, September 2015 58
5.6.2 Pharmaceuticals & Healthcare, Global, Top Licensing Agreements, by Total Upfront Payments, September 2015 59
5.6.3 Pharmaceuticals & Healthcare, Global, Top Licensing Agreements by Total Milestone Payment, September 2015 60
Make an Enquiry of this report @ http://www.researchmoz.us/enquiry.php?type=E&repid=487735
About ResearchMoz
ResearchMoz is the one stop online destination to find and buy market research reports & Industry Analysis. We fulfill all your research needs spanning across industry verticals with our huge collection of market research reports. We provide our services to all sizes of organizations and across all industry verticals and markets. Our Research Coordinators have in-depth knowledge of reports as well as publishers and will assist you in making an informed decision by giving you unbiased and deep insights on which reports will satisfy your needs at the best price.
For More Information Kindly Contact:
ResearchMoz
Mr. Nachiket Ghumare,
Tel: +1-518-621-2074
USA-Canada Toll Free: 866-997-4948
Email: sales@researchmoz.us
Website: http://www.researchmoz.us/
For More Reports Please Visit @ http://www.prnewswire.com/news/researchmoz
For More Reports Please Visit @ http://www.sbwire.com/search/?q=researchmoz
Researchmoz Global Pvt.Ltd
Researchmoz
+1-518-621-2074
sales@researchmoz.us
Source: EmailWire.Com 
|
